Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  checkpoint kinase 1 inhibitor LY2606368
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
LY2606368 in Treating Patients with BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-high Risk Triple Negative Breast Cancer, or High Grade Ovarian Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0156, NCI-2014-02304, 140156, 342996, P131428, NCT02203513
A Study of LY2606368 With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15295, NCI-2014-01348, I4D-MC-JTJF, NCT02124148
Start Over